Request Deal Involvement
HitGen to acquire Vernalis' research operations from Ligand for $25m.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
pr advisors
Lippert/Heilshorn & Associates
legal advisors
Latham & Watkins
or
Principals
target
VERNALIS (RESEARCH & DEVELOPMENT UNIT)
vendor
LIGAND PHARMACEUTICALS INC
bidder
HITGEN INC
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite